Sean M. Healey & AMG Center for ALS
The Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital is thrilled to announce the launch of our newest initiative, ALS MyMatch, an innovative, early phase, biomarker-driven clinical trial network program.
Learn MoreA combination therapy of ciprofloxacin and celecoxib demonstrated a favorable safety profile for those with amyotrophic lateral sclerosis. Features Merit Cudkowicz, MD, MSc.
ALS patients and advocates called on lawmakers to commit more funding to help with disease research on Thursday, May 2.
Join our quest to discover life-saving therapies for individuals who are affected by ALS. The key to our success is our dedication to collaboration. At the Sean M. Healey and AMG Center for ALS at Mass General, we partner with the best clinician-scientists, our patients and friends like you to turn laboratory successes into promising therapies.
